Buy ILARIS 150 SW Canakinumab

ILARIS 150 SW (Canakinumab 150mg/ml) is an injectable prescription medication used for inflammatory conditions. Store at 2-8°C to maintain potency. Suitable for adults and children with specific autoinflammatory disorders. Always follow healthcare provider guidance when using this vial form.

Strength

150mg/ml x 1ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

NOVARTIS PHARMA SCHWEIZ

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Canakinumab is prescribed to reduce inflammation in conditions like Still’s disease and certain periodic fever syndromes. It works by targeting specific proteins in the immune system to help control symptoms. This vial form allows precise dosing for patients requiring subcutaneous injection. Commonly used when other treatments have not provided adequate relief.

Side Effects

Many patients experience reduced joint pain and swelling after starting Canakinumab therapy. Some report improved mobility and fewer disease flare-ups over time. Individual responses vary based on condition severity and treatment duration. Regular monitoring helps assess ongoing effectiveness.

Precautions & Warnings

Keep ILARIS 150 SW refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Inspect vials for particles or discoloration before use. Dispose of used needles properly in a sharps container. Always wash hands before handling medication.

Avoid Interactions

Avoid live vaccines during Canakinumab treatment due to potential reduced immune response. Some medications like certain immunosuppressants may increase infection risk when combined. Always inform your healthcare provider about all current medications. Alcohol use should be discussed with a medical professional.

References

Frequently Asked Questions

Canakinumab is used for autoinflammatory conditions like Still’s disease and periodic fever syndromes.

This medication comes as a pre-filled vial for subcutaneous injection, typically given by a healthcare professional.

No, Canakinumab requires a valid prescription from a licensed healthcare provider for legal purchase.

Contact your healthcare provider for guidance if a dose is missed; do not take extra doses without medical advice.

Some patients report injection site reactions or mild infections; discuss any concerns with your doctor.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.